From in-silico QSAR modeling to in-vitro MTT assay - experimental validation of novel uPAR leads for triple-negative breast cancer (TNBC) and skin cancer
Favorite
Share
More Options
42

Open in WPS to view all 42 pages
This document is user-generated content (UGC). WPS Office is not responsible for its accuracy or copyright. If you believe this content violates your rights, please use the button.
